Menu

CME Corner

This activity has expired. CME/CE credit is no longer available and the following content may not be available or may not be up-to-date. For a list of current activities that offer CME/CE credit, click here.

Program Detail

Release Date: February-09-09
Credit Expiration Date: December-31-10

Faculty

Mario Cornacchione DO, CMD, FAAFP
Clinical Associate Professor of Medicine
Department of Family Medicine
The Commonwealth Medical College
Scranton, Pennsylvania
Clinical Assistant Professor of Medicine
Institute for Successful Aging
University of Medicine & Dentistry of NJ
Stratford, New Jersey
Program Director
Northeastern Pennsylvania Memory & Alzheimer’s Center
Medical Director
Golden Living Summit
Wilkes Barre, Pennsylvania

Nancy L. Losben, RPh, CCP, FASCP, CG
Chief Quality Officer
Omnicare
Moorestown, New Jersey

Credit Hours

1

Medium

Online Presentation

Program Description

THIS PROGRAM WAS ORIGINALLY PRESENTED AS A LIVE AUDIOCONFERENCE BEGINNING ON FEBRUARY 9, 2009. IF YOU RECEIVED CREDIT FOR PARTICIPATING IN THE AUDIOCONFERENCE, YOU ARE NOT ELIGIBLE TO RECEIVE CREDIT FOR THIS ONLINE VERSION.

Long-term care facilities, many of which are already overpopulated and understaffed, will be facing even greater demands over the next several years. As the massive baby boom generation enters retirement, the number of Americans over the age of 65 will double to more than 71 million, comprising roughly 20% of the United States’ population. By more effectively treating the healthcare needs of this maturing demographic, long-term care providers will improve patient outcomes and quality indicators as well as reduce costs and adverse events. An often overlooked aspect of overall patient care is constipation. When left untreated or improperly treated, chronic constipation can result in complications such as fecal impaction, infection, perforation, and possibly death. The prevalence of constipation increases with age, most markedly in those 65 and older. In this age group, approximately 26% of men and 34% of women complain of constipation. As the elderly population grows, increasingly higher percentages of long-term care patients will require treatment and monitoring for the symptoms of constipation. Effective treatment and monitoring strategies will be outlined in this on-line program.

Target Audience

This program was designed for medical directors, other physicians, nurse practitioners, nurses, and pharmacists caring for older adults.

Learning Objectives

Upon completion of this educational activity, the participant should be able to:

  1. Recommend a therapeutic regimen that uses available pharmacologic options for treating chronic constipation in the geriatric patient.
  2. Identify potential caregiver challenges to patient care management and administration of medications.
  3. Depict practical management strategies for elderly patients with chronic constipation to optimize patient outcomes.
  4. Describe an organization-wide approach to monitoring potential adverse effects of treatment for constipation such as fecal impaction, nausea, and diarrhea.

Disclosures

It is the policy of ASCP, in accordance with the guidelines set forth by the Accreditation Council for Pharmacy Education, and AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of their continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflict of interest is resolved by ASCP and AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

The intent of this disclosure is not to prevent a presenter with significant financial interest or other relationship from making the presentation, but rather to provide the audience with information with which they can make their own judgments. It remains for the audience to determine whether the speakers’ interests or relationships may influence the presentation with regard to exposition or conclusion. Faculty are also expected to openly disclose any off-label, experimental, or investigational use of drugs or devices in their presentations.

Mario Cornacchione DO, CMD, FAAFP, has no commercial interests to disclose.

Nancy L. Losben, RPh, CCP, FASCP, CG, served as an advisory board member for Sucampo Pharmaceuticals, Inc., in 2007.

Credit Statements

Pharmacists: The American Society of Consultant Pharmacists (ASCP) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program (UAN 203-999-09-001-H01-P) was developed by ASCP and is approved for 1.0 Contact Hour (0.1 CEU).

Physicians: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of AKH Inc. and Medical Communications Media.

AKH Inc. is accredited by the ACCME to provide continuing medical education for physicians. AKH Inc. designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurse Practitioners: AKH Inc. is accredited by the American Academy of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number 030803. AKH Inc. designates this educational activity for 1 contact hour, which includes 0.5 pharmacology contact hour.

Nurses: NADONA/LTC is an approved provider of continuing nursing education by Georgia Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation #1087. This program provides 1 contact hour by NADONA/LTC.


Participants must successfully complete the post-test (70% or higher) and submit an evaluation to receive credit. A statement of credit will be available immediately if the post-test and evaluation are completed online.

The initial release date of this activity is February 9, 2009.

Commercial Support Statements

This activity is supported by an educational grant from Sucampo Pharmaceuticals, Inc. & Takeda Pharmaceuticals North America, Inc.

Instructions

Please turn off all pop-up blockers to assure access to the educational activity.

  1. Click on the "Start program" icon. If you are not already registered as a user of this website, this will bring you to the login/registration page where you will be able to register as a new CMEcorner.com member or check existing registration information. When ready, click on the "Continue to Program" icon at the bottom of the screen. Complete the short survey and click on "done."
  2. The next screen will permit you to check for or download the Flash player required to run this program and to begin the program presentation. The activity will take approximately 60 minutes to complete.
  3. After the program has finished, click on the "Post-test" button. Complete the short survey and click on "done."
  4. Instructions for completing and submitting the post-test and evaluation are provided on the post-test screen. A credit statement/certificate will be awarded for a score of 70% or better and may be printed immediately after passing the post-test.

Certificate Fee

$0.00

Disclaimer

©2009 Medical Communications Media, Inc. All rights reserved. The opinions expressed in this program are those of the speakers and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, AKH Inc., the American Society of Consultant Pharmacists, the National Association of Directors of Nursing Administration in Long-Term Care, Sucampo Pharmaceuticals, Inc., or Takeda Pharmaceuticals North America, Inc. Any medications or other diagnostic or treatment procedures discussed by the program speakers should not be utilized by clinicians without evaluation of their patients’ conditions and of possible contraindications or risks, and without a review of any applicable manufacturer’s product information and comparison with the recommendations of other authorities.

By clicking START PROGRAM I acknowledge that I have read the CME/CE information above.

Main Menu
EDITOR'S PICKS